| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gene Expression Via an Autoregulatory Loop Mechanism
Department of Biotechnology (Y.L., C.B., J.W.-D., S.L., S.K.P., C.X., D.S.L.), Mail Zone AA305E, Pharmacia Corp., St. Louis, Missouri 63198; Department of Cardiovascular and Metabolic Disease (G.B.), Pharmacia Corp., Creve Couer, St. Louis, Missouri 63167
Address all correspondence and requests for reprints to: Dr. Deepak Lala, Department of Biochemistry and Molecular Biology, Pharmacia Corp., 700 Chesterfield Parkway North, St. Louis, Missouri 63198.
The liver X receptors (LXRs), members of the nuclear receptor superfamily, play an important role in controlling lipid homeostasis by activating several genes involved in reverse cholesterol transport. These include members of the ATP binding cassette (ABC) superfamily of transporter proteins ABCA1 and ABCG1, surface constituents of plasma lipoproteins like apolipoprotein E, and cholesterol ester transport protein. They also play an important role in fatty acid metabolism by activating the sterol regulatory element-binding protein 1c gene. Here, we identify human LXR
(hLXR
) as an autoinducible gene. Induction in response to LXR ligands is observed in multiple human cell types including macrophages and occurs within 24 h. Analysis of the hLXR
promoter revealed three LXR response elements (LXREs); one exhibits strong affinity for both LXR
:RXR and LXRß:RXR (a type I LXRE), and deletion and mutational studies indicate it plays a critical role in LXR-mediated induction. The other two LXREs are identical to each other, exist within highly conserved Alu repeats, and exhibit selective binding to LXR
:RXR (type II LXREs). In transfections, the type I LXRE acts as a strong mediator of both LXR
and LXRß activity, whereas the type II LXRE acts as a weaker and selective mediator of LXR
activity. Our data suggest a model in which LXR ligands trigger an autoregulatory loop leading to selective induction of hLXR
gene expression. This would lead to increased hLXR
levels and transcription of its downstream target genes such as ABCA1, providing a simple yet exquisite mechanism for cells to respond to LXR ligands and cholesterol loading.
This article has been cited by other articles:
![]() |
R. Geyeregger, M. Shehata, M. Zeyda, F. W. Kiefer, K. M. Stuhlmeier, E. Porpaczy, G. J. Zlabinger, U. Jager, and T. M. Stulnig Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes J. Leukoc. Biol., November 1, 2009; 86(5): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmuth, Y. J. Jiang, S. Dubrac, P. M. Elias, and K. R. Feingold Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology J. Lipid Res., March 1, 2008; 49(3): 499 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stayrook, P. M. Rogers, R. S. Savkur, Y. Wang, C. Su, G. Varga, X. Bu, T. Wei, S. Nagpal, X. S. Liu, et al. Regulation of Human 3{alpha}-Hydroxysteroid Dehydrogenase (AKR1C4) Expression by the Liver X Receptor {alpha} Mol. Pharmacol., February 1, 2008; 73(2): 607 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, S. Matsumoto, M. Yamada, T. Satoh, and M. Mori Liver X Receptor-{alpha} Gene Expression Is Positively Regulated by Thyroid Hormone Endocrinology, October 1, 2007; 148(10): 4667 - 4675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geyeregger, M. Zeyda, W. Bauer, E. Kriehuber, M. D. Saemann, G. J. Zlabinger, D. Maurer, and T. M. Stulnig Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin Blood, May 15, 2007; 109(10): 4288 - 4295. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, R. N. Cohen, M. Yamada, K. R. Markan, T. Monden, T. Satoh, M. Mori, and F. E. Wondisford Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model J. Biol. Chem., January 6, 2006; 281(1): 295 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Steffensen, S. Y. Neo, T. M Stulnig, V. B Vega, S. S Rahman, G. U Schuster, J.-A. Gustafsson, and E. T Liu Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals J. Mol. Endocrinol., December 1, 2004; 33(3): 609 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ulven, K. T. Dalen, J.-A. Gustafsson, and H. I. Nebb Tissue-specific autoregulation of the LXR{alpha} gene facilitates induction of apoE in mouse adipose tissue J. Lipid Res., November 1, 2004; 45(11): 2052 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Quinet, D. A. Savio, A. R. Halpern, L. Chen, C. P. Miller, and P. Nambi Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor J. Lipid Res., October 1, 2004; 45(10): 1929 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Lew, A. Zhao, J. Yu, L. Huang, N. de Pedro, F. Pelaez, S. D. Wright, and J. Cui The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion J. Biol. Chem., March 5, 2004; 279(10): 8856 - 8861. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Steffensen and J.-A. Gustafsson Putative Metabolic Effects of the Liver X Receptor (LXR) Diabetes, February 1, 2004; 53(90001): S36 - 42. [Abstract] [Full Text] |
||||
![]() |
J. M. Maglich, J. A. Caravella, M. H. Lambert, T. M. Willson, J. T. Moore, and L. Ramamurthy The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily Nucleic Acids Res., July 15, 2003; 31(14): 4051 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, S. Li, J. Wu, C. Xia, and D. S. Lala Liver X Receptors Interact with Corepressors to Regulate Gene Expression Mol. Endocrinol., June 1, 2003; 17(6): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Le Goff, M. Guerin, M. J. Chapman, and J. Thillet A CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression J. Lipid Res., May 1, 2003; 44(5): 902 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Meyer, J.-S. Lee, P. A. Dyck, W.-Q. Cao, M.S. Rao, S. S. Thorgeirsson, and J. K. Reddy Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen Carcinogenesis, May 1, 2003; 24(5): 975 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Stulnig, K. R. Steffensen, H. Gao, M. Reimers, K. Dahlman-Wright, G. U. Schuster, and J.-A. Gustafsson Novel Roles of Liver X Receptors Exposed by Gene Expression Profiling in Liver and Adipose Tissue Mol. Pharmacol., December 1, 2002; 62(6): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |